HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Clinical trials for HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat ovarian cancer
Disease control CompletedThis phase 2 trial tested a drug called mirvetuximab soravtansine in 79 people with recurrent platinum-sensitive ovarian, peritoneal, or fallopian tube cancers that have high levels of a protein called folate receptor-alpha. The drug is given by IV every three weeks. The main goa…
Matched conditions: HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
DNA blood test could catch ovarian cancer sooner
Diagnosis CompletedThis study aimed to find DNA markers in the blood that could help detect a serious type of ovarian cancer early. Researchers compared DNA from women with and without ovarian cancer to identify differences. The goal is to develop a simple blood test for earlier diagnosis. Ten wome…
Matched conditions: HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
Sponsor: Baylor Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC